CB vs NRIX · P/E 14, rev $59.40B vs rev $54.5M
Chubb Ltd (CB) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
CB currently screens at market cap $114.26B and trailing P/E 13.7. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the CB and NRIX stock pages for the full models.
Not investment advice.